US 12310944
Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof
granted A61KA61K31/167A61K31/195
Quick answer
US patent 12310944 (Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA PHARMACEUTICAL UNIVERSITY
- Grant date
- Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/167, A61K31/195, A61K31/24, A61K31/277